DOC - NYSE
Healthpeak Properties, Inc.
$19.60
+0.77%Healthpeak Properties, Inc. is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.
At a Glance
Live SnapshotHealthpeak Properties, Inc. Management Team
Mr. Scott R. Bohn
Chief Development Officer & Head of Lab
Compensation
$1,404,996
Mr. Kelvin O. Moses
Chief Financial Officer
Mr. Adam G. Mabry
Chief Investment Officer
Compensation
$1,380,823
Mr. Thomas M. Klaritch
Consultant
Compensation
$2,142,788
Mr. Shawn G. Johnston
Executive Vice President & Chief Accounting Officer
Ms. Lisa A. Alonso
Executive Vice President & Chief Human Resources Officer
Ms. Tracy A. Porter
Executive Vice President, General Counsel & ESG
Mr. Scott M. Brinker
President, Chief Executive Officer & Director
Compensation
$2,751,476
Mr. Andrew Johns CFA
Senior Vice President of Investor Relations
Mr. James A. Croy
Senior Vice President of Leasing - Outpatient Medical
Healthpeak Properties, Inc. Insider Positioning
During the last 12 months, insiders have purchased $150K and sold $214K worth of DOC shares, resulting in $64K of net selling activity.
3 Months
0
0.00
11.0K
213.74K
-214K
-$214K
3-6 Months
0
0.00
0
0.00
+0
+$0
6-9 Months
0
0.00
0
0.00
+0
+$0
9-12 Months
8.7K
149.78K
0
0.00
+150K
+$150K
Top Buyers
Brinker Scott M
Director, Officer: President And Ceo
$125K
Thomas John T
Director
$25K
Top Sellers
Bohn Scott R
Officer: Cdo And Head Of Lab
$214K
Insider Activity Analysis
Net Insider Sentiment
Slightly bearish with $64K net selling. Selling modestly exceeds buying, which could be routine diversification rather than concern.
Buy/Sell Ratio
Moderately negative ratio. Selling is roughly double the buying, which may be routine or signal caution.
Recent Trend (3 Months)
Heavy recent selling activity. Recent insider sales notably exceed purchases—may warrant investigation into company developments.
Insider Participation
2 insider buyers vs. 1 sellers. More insiders buying than selling indicates positive sentiment.
SEC Filings
DOC - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
DEF 14A DEF 14A 2026 N/A | March 12, 2026 | April 30, 2026 | 2026 | |
DEF 14A DEF 14A 2025 N/A | March 12, 2025 | April 24, 2025 | 2025 | |
DEF 14A DEF 14A 2024 N/A | March 13, 2024 | April 25, 2024 | 2024 | |
DEF 14A DEF 14A N/A | March 17, 2023 | March 17, 2023 | ||
DEF 14A DEF 14A 2022 N/A | March 17, 2022 | April 28, 2022 | 2022 | |
DEF 14A DEF 14A 2021 N/A | March 18, 2021 | April 28, 2021 | 2021 | |
DEF 14A DEF 14A 2020 N/A | March 12, 2020 | April 23, 2020 | 2020 | |
DEF 14A DEF 14A 2019 N/A | March 14, 2019 | April 25, 2019 | 2019 | |
DEF 14A DEF 14A 2018 N/A | March 16, 2018 | April 26, 2018 | 2018 | |
DEF 14A DEF 14A 2017 N/A | March 16, 2017 | April 27, 2017 | 2017 |
Research Paths
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.